Share Price and Basic Stock Data
Last Updated: March 3, 2026, 1:34 pm
| PEG Ratio | 27.36 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vakrangee Ltd, operating in the IT Consulting and Software sector, reported a market capitalization of ₹715 Cr and a share price of ₹6.60. The company’s revenue trajectory has shown fluctuations, with sales for the trailing twelve months (TTM) standing at ₹261 Cr. Notably, revenue has seen a gradual increase from ₹197 Cr in March 2023 to ₹255 Cr in March 2025. Quarterly sales figures indicate a peak of ₹69.08 Cr in September 2025, reflecting a consistent upward trend despite a slight decline to ₹60.10 Cr in December 2025. The company’s operating profit margin (OPM) recorded an average of 11.02% for March 2025, demonstrating a competitive position within the industry. The reported sales figures reflect strong operational efforts, with a notable recovery from the lows experienced in previous years, particularly the significant drop to ₹314 Cr in March 2021 and ₹194 Cr in March 2022 due to adverse market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Vakrangee Ltd | 674 Cr. | 6.22 | 14.2/6.16 | 57.7 | 1.93 | 0.00 % | 5.86 % | 3.65 % | 1.00 |
| Mindteck (India) Ltd | 659 Cr. | 206 | 308/141 | 21.9 | 87.7 | 0.49 % | 15.5 % | 12.5 % | 10.0 |
| Allied Digital Services Ltd | 638 Cr. | 113 | 227/102 | 17.4 | 108 | 1.33 % | 10.9 % | 5.31 % | 5.00 |
| Xchanging Solutions Ltd | 721 Cr. | 64.7 | 105/62.7 | 12.5 | 32.9 | 3.09 % | 15.4 % | 13.9 % | 10.0 |
| Onward Technologies Ltd | 605 Cr. | 266 | 385/206 | 12.8 | 102 | 1.88 % | 15.6 % | 12.5 % | 10.0 |
| Industry Average | 17,216.49 Cr | 440.02 | 101.72 | 121.85 | 0.73% | 14.90% | 21.00% | 6.84 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.15 | 50.94 | 55.59 | 51.54 | 51.56 | 53.89 | 58.70 | 65.25 | 67.88 | 63.18 | 68.84 | 69.08 | 60.10 |
| Expenses | 44.15 | 46.22 | 48.97 | 45.62 | 45.33 | 46.28 | 52.14 | 60.01 | 62.40 | 56.35 | 61.02 | 61.81 | 52.31 |
| Operating Profit | 5.00 | 4.72 | 6.62 | 5.92 | 6.23 | 7.61 | 6.56 | 5.24 | 5.48 | 6.83 | 7.82 | 7.27 | 7.79 |
| OPM % | 10.17% | 9.27% | 11.91% | 11.49% | 12.08% | 14.12% | 11.18% | 8.03% | 8.07% | 10.81% | 11.36% | 10.52% | 12.96% |
| Other Income | -0.05 | 0.86 | 0.31 | 0.87 | 1.32 | 0.39 | 0.89 | 0.82 | 0.75 | 1.55 | 1.51 | 1.64 | 1.47 |
| Interest | 0.00 | 1.52 | 1.99 | 1.83 | 1.93 | 1.96 | 0.45 | 0.60 | 0.38 | 0.40 | 0.36 | 0.35 | 0.44 |
| Depreciation | 4.01 | 3.39 | 3.95 | 3.97 | 3.92 | 3.85 | 3.89 | 4.28 | 4.24 | 4.29 | 4.30 | 4.45 | 4.61 |
| Profit before tax | 0.94 | 0.67 | 0.99 | 0.99 | 1.70 | 2.19 | 3.11 | 1.18 | 1.61 | 3.69 | 4.67 | 4.11 | 4.21 |
| Tax % | 86.17% | -1.49% | 49.49% | 57.58% | 26.47% | 0.00% | 27.97% | 50.85% | 35.40% | 31.71% | 28.91% | 26.28% | 25.18% |
| Net Profit | 0.13 | 0.68 | 0.49 | 0.42 | 1.24 | 2.19 | 2.24 | 0.59 | 1.04 | 2.52 | 3.32 | 3.03 | 3.15 |
| EPS in Rs | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 |
Last Updated: February 3, 2026, 4:46 pm
Below is a detailed analysis of the quarterly data for Vakrangee Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 60.10 Cr.. The value appears to be declining and may need further review. It has decreased from 69.08 Cr. (Sep 2025) to 60.10 Cr., marking a decrease of 8.98 Cr..
- For Expenses, as of Dec 2025, the value is 52.31 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 61.81 Cr. (Sep 2025) to 52.31 Cr., marking a decrease of 9.50 Cr..
- For Operating Profit, as of Dec 2025, the value is 7.79 Cr.. The value appears strong and on an upward trend. It has increased from 7.27 Cr. (Sep 2025) to 7.79 Cr., marking an increase of 0.52 Cr..
- For OPM %, as of Dec 2025, the value is 12.96%. The value appears strong and on an upward trend. It has increased from 10.52% (Sep 2025) to 12.96%, marking an increase of 2.44%.
- For Other Income, as of Dec 2025, the value is 1.47 Cr.. The value appears to be declining and may need further review. It has decreased from 1.64 Cr. (Sep 2025) to 1.47 Cr., marking a decrease of 0.17 Cr..
- For Interest, as of Dec 2025, the value is 0.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.35 Cr. (Sep 2025) to 0.44 Cr., marking an increase of 0.09 Cr..
- For Depreciation, as of Dec 2025, the value is 4.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.45 Cr. (Sep 2025) to 4.61 Cr., marking an increase of 0.16 Cr..
- For Profit before tax, as of Dec 2025, the value is 4.21 Cr.. The value appears strong and on an upward trend. It has increased from 4.11 Cr. (Sep 2025) to 4.21 Cr., marking an increase of 0.10 Cr..
- For Tax %, as of Dec 2025, the value is 25.18%. The value appears to be improving (decreasing) as expected. It has decreased from 26.28% (Sep 2025) to 25.18%, marking a decrease of 1.10%.
- For Net Profit, as of Dec 2025, the value is 3.15 Cr.. The value appears strong and on an upward trend. It has increased from 3.03 Cr. (Sep 2025) to 3.15 Cr., marking an increase of 0.12 Cr..
- For EPS in Rs, as of Dec 2025, the value is 0.03. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: February 26, 2026, 9:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,952 | 2,780 | 3,191 | 4,000 | 6,502 | 1,508 | 685 | 314 | 194 | 197 | 213 | 255 | 261 |
| Expenses | 1,417 | 2,057 | 2,370 | 3,054 | 5,495 | 1,530 | 661 | 286 | 176 | 179 | 186 | 231 | 231 |
| Operating Profit | 535 | 723 | 821 | 946 | 1,007 | -22 | 24 | 28 | 18 | 19 | 26 | 24 | 30 |
| OPM % | 27% | 26% | 26% | 24% | 15% | -1% | 3% | 9% | 9% | 9% | 12% | 9% | 11% |
| Other Income | 6 | 6 | 6 | 5 | 34 | 82 | 83 | 70 | 2 | 1 | 3 | 4 | 6 |
| Interest | 78 | 75 | 56 | 50 | 10 | -0 | -0 | -0 | -0 | 2 | 8 | 2 | 2 |
| Depreciation | 181 | 165 | 164 | 73 | 7 | 9 | 15 | 15 | 15 | 16 | 16 | 17 | 18 |
| Profit before tax | 282 | 489 | 606 | 828 | 1,024 | 51 | 92 | 83 | 5 | 3 | 6 | 10 | 17 |
| Tax % | 38% | 34% | 35% | 36% | 34% | 51% | 22% | 24% | 100% | 63% | 26% | 33% | |
| Net Profit | 175 | 322 | 395 | 531 | 680 | 25 | 71 | 63 | -0 | 1 | 4 | 6 | 12 |
| EPS in Rs | 1.74 | 3.20 | 3.73 | 5.02 | 6.43 | 0.24 | 0.67 | 0.59 | -0.00 | 0.01 | 0.04 | 0.06 | 0.11 |
| Dividend Payout % | 7% | 4% | 17% | 20% | 4% | 105% | 37% | 17% | 530% | 122% | -0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 84.00% | 22.67% | 34.43% | 28.06% | -96.32% | 184.00% | -11.27% | -100.00% | 300.00% | 50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -61.33% | 11.76% | -6.37% | -124.38% | 280.32% | -195.27% | -88.73% | 400.00% | -250.00% |
Vakrangee Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -18% |
| 3 Years: | 10% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -37% |
| 3 Years: | % |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -16% |
| 5 Years: | -19% |
| 3 Years: | -34% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: February 1, 2026, 4:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 53 | 53 | 106 | 106 | 106 | 106 | 106 | 106 | 106 | 108 | 108 |
| Reserves | 729 | 1,157 | 1,530 | 2,001 | 2,487 | 2,496 | 2,531 | 2,558 | 22 | 18 | 56 | 94 | 100 |
| Borrowings | 492 | 416 | 320 | 144 | 0 | 0 | 0 | 0 | 27 | 58 | 12 | 5 | 4 |
| Other Liabilities | 453 | 414 | 189 | 71 | 400 | 116 | 182 | 212 | 178 | 116 | 126 | 102 | 130 |
| Total Liabilities | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
| Fixed Assets | 436 | 273 | 132 | 29 | 90 | 143 | 149 | 156 | 139 | 127 | 114 | 110 | 119 |
| CWIP | 48 | 10 | 0 | 0 | 3 | 13 | 5 | 5 | 6 | 8 | 10 | 17 | 9 |
| Investments | 3 | 2 | 2 | 2 | 29 | 4 | 3 | 1 | 2 | 3 | 7 | 4 | 5 |
| Other Assets | 1,238 | 1,753 | 1,959 | 2,238 | 2,871 | 2,558 | 2,662 | 2,714 | 186 | 160 | 169 | 177 | 210 |
| Total Assets | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
Below is a detailed analysis of the balance sheet data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 108.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 108.00 Cr..
- For Reserves, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 28.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 343.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2025) to 119.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
Notably, the Reserves (100.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 43.00 | 307.00 | 501.00 | 802.00 | 1.00 | -22.00 | 24.00 | 28.00 | -9.00 | -39.00 | 14.00 | 19.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 144 | 157 | 97 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 39 |
| Inventory Days | 45 | 31 | 81 | 223 | ||||||||
| Days Payable | 71 | 39 | 18 | 217 | ||||||||
| Cash Conversion Cycle | 119 | 149 | 160 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 45 |
| Working Capital Days | 66 | 124 | 137 | 129 | 55 | 310 | 894 | 2,188 | -145 | -53 | -6 | 4 |
| ROCE % | 31% | 39% | 37% | 43% | 43% | 2% | 3% | 3% | 0% | 3% | 7% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Diluted EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Cash EPS (Rs.) | 0.21 | 0.18 | 0.15 | 1.18 | 0.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Revenue From Operations / Share (Rs.) | 2.35 | 2.01 | 1.86 | 7.35 | 2.97 |
| PBDIT / Share (Rs.) | 0.25 | 0.27 | 0.18 | 1.50 | 0.92 |
| PBIT / Share (Rs.) | 0.10 | 0.12 | 0.03 | 1.35 | 0.78 |
| PBT / Share (Rs.) | 0.08 | 0.05 | 0.02 | 1.34 | 0.78 |
| Net Profit / Share (Rs.) | 0.05 | 0.04 | 0.01 | 1.03 | 0.59 |
| NP After MI And SOA / Share (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| PBDIT Margin (%) | 11.02 | 13.51 | 9.98 | 20.37 | 31.06 |
| PBIT Margin (%) | 4.48 | 6.12 | 2.12 | 18.39 | 26.35 |
| PBT Margin (%) | 3.76 | 2.75 | 1.35 | 18.17 | 26.35 |
| Net Profit Margin (%) | 2.50 | 2.04 | 0.50 | 14.06 | 19.97 |
| NP After MI And SOA Margin (%) | 2.61 | 2.04 | 0.50 | 14.06 | 19.97 |
| Return on Networth / Equity (%) | 3.75 | 3.61 | 0.81 | 3.98 | 2.35 |
| Return on Capital Employeed (%) | 4.85 | 6.92 | 2.68 | 5.20 | 3.10 |
| Return On Assets (%) | 2.15 | 1.45 | 0.33 | 3.73 | 2.18 |
| Long Term Debt / Equity (X) | 0.00 | 0.06 | 0.10 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.10 | 0.46 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.83 | 0.71 | 0.10 | 0.24 | 0.08 |
| Current Ratio (X) | 2.15 | 1.40 | 1.05 | 11.93 | 10.20 |
| Quick Ratio (X) | 1.90 | 1.40 | 1.04 | 11.90 | 10.17 |
| Inventory Turnover Ratio (X) | 26.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 81.17 | 121.71 | 527.21 | 9.67 | 42.17 |
| Dividend Payout Ratio (CP) (%) | 23.13 | 26.43 | 32.07 | 8.47 | 34.13 |
| Earning Retention Ratio (%) | 18.83 | -21.71 | -427.21 | 90.33 | 57.83 |
| Cash Earning Retention Ratio (%) | 76.87 | 73.57 | 67.93 | 91.53 | 65.87 |
| Interest Coverage Ratio (X) | 15.39 | 3.72 | 13.01 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 4.50 | 1.49 | 1.66 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 947.72 | 2066.51 | 1718.30 | 3625.04 | 5916.69 |
| EV / Net Operating Revenue (X) | 3.72 | 9.72 | 8.71 | 4.66 | 18.83 |
| EV / EBITDA (X) | 33.70 | 71.95 | 87.18 | 22.84 | 60.61 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| Retention Ratios (%) | 18.82 | -21.71 | -427.21 | 90.32 | 57.82 |
| Price / BV (X) | 5.75 | 17.47 | 13.70 | 1.34 | 2.23 |
| Price / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
After reviewing the key financial ratios for Vakrangee Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.35. It has increased from 2.01 (Mar 24) to 2.35, marking an increase of 0.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 0.27 (Mar 24) to 0.25, marking a decrease of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.10, marking a decrease of 0.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For PBDIT Margin (%), as of Mar 25, the value is 11.02. This value is within the healthy range. It has decreased from 13.51 (Mar 24) to 11.02, marking a decrease of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 10. It has decreased from 6.12 (Mar 24) to 4.48, marking a decrease of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 3.76. This value is below the healthy minimum of 10. It has increased from 2.75 (Mar 24) to 3.76, marking an increase of 1.01.
- For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has increased from 2.04 (Mar 24) to 2.50, marking an increase of 0.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 8. It has increased from 2.04 (Mar 24) to 2.61, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 15. It has increased from 3.61 (Mar 24) to 3.75, marking an increase of 0.14.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has decreased from 6.92 (Mar 24) to 4.85, marking a decrease of 2.07.
- For Return On Assets (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from 1.45 (Mar 24) to 2.15, marking an increase of 0.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.00, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 2.15, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 1.90, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 26.84. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 26.84, marking an increase of 26.84.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.17. This value exceeds the healthy maximum of 50. It has decreased from 121.71 (Mar 24) to 81.17, marking a decrease of 40.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 23.13. This value is within the healthy range. It has decreased from 26.43 (Mar 24) to 23.13, marking a decrease of 3.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.83. This value is below the healthy minimum of 40. It has increased from -21.71 (Mar 24) to 18.83, marking an increase of 40.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 76.87. This value exceeds the healthy maximum of 70. It has increased from 73.57 (Mar 24) to 76.87, marking an increase of 3.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 15.39, marking an increase of 11.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.50. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 4.50, marking an increase of 3.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 947.72. It has decreased from 2,066.51 (Mar 24) to 947.72, marking a decrease of 1,118.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 3.72, marking a decrease of 6.00.
- For EV / EBITDA (X), as of Mar 25, the value is 33.70. This value exceeds the healthy maximum of 15. It has decreased from 71.95 (Mar 24) to 33.70, marking a decrease of 38.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For Retention Ratios (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 30. It has increased from -21.71 (Mar 24) to 18.82, marking an increase of 40.53.
- For Price / BV (X), as of Mar 25, the value is 5.75. This value exceeds the healthy maximum of 3. It has decreased from 17.47 (Mar 24) to 5.75, marking a decrease of 11.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vakrangee Ltd:
- Net Profit Margin: 2.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.85% (Industry Average ROCE: 14.9%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.75% (Industry Average ROE: 21%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.7 (Industry average Stock P/E: 101.72)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Vakrangee Corporate House, Plot No 93, Road No. 16, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Divya Nandwana | Executive Chairperson |
| Mr. Vedant Nandwana | Managing Director |
| Mr. Hari Chand Mittal | Ind. Non-Executive Director |
| Ms. Savita Keni | Independent Director |
| Mr. L K Shamsunder | Non Exe.Non Ind. & Nominee Director |
| Mr. Sandeep Gaware | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Vakrangee Ltd?
Vakrangee Ltd's intrinsic value (as of 04 March 2026) is ₹3.39 which is 45.50% lower the current market price of ₹6.22, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹674 Cr. market cap, FY2025-2026 high/low of ₹14.2/6.16, reserves of ₹100 Cr, and liabilities of ₹343 Cr.
What is the Market Cap of Vakrangee Ltd?
The Market Cap of Vakrangee Ltd is 674 Cr..
What is the current Stock Price of Vakrangee Ltd as on 04 March 2026?
The current stock price of Vakrangee Ltd as on 04 March 2026 is ₹6.22.
What is the High / Low of Vakrangee Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vakrangee Ltd stocks is ₹14.2/6.16.
What is the Stock P/E of Vakrangee Ltd?
The Stock P/E of Vakrangee Ltd is 57.7.
What is the Book Value of Vakrangee Ltd?
The Book Value of Vakrangee Ltd is 1.93.
What is the Dividend Yield of Vakrangee Ltd?
The Dividend Yield of Vakrangee Ltd is 0.00 %.
What is the ROCE of Vakrangee Ltd?
The ROCE of Vakrangee Ltd is 5.86 %.
What is the ROE of Vakrangee Ltd?
The ROE of Vakrangee Ltd is 3.65 %.
What is the Face Value of Vakrangee Ltd?
The Face Value of Vakrangee Ltd is 1.00.
